EPD vs. ABBV
Compare and contrast key facts about Enterprise Products Partners L.P. (EPD) and AbbVie Inc. (ABBV).
Performance
EPD vs. ABBV - Performance Comparison
Loading graphics...
EPD vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EPD Enterprise Products Partners L.P. | 19.96% | 9.45% | 28.00% | 17.71% | 18.32% | 21.40% | -23.61% | 21.88% | -1.32% | 4.24% |
ABBV AbbVie Inc. | -4.05% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Fundamentals
EPD:
$82.68B
ABBV:
$385.83B
EPD:
$2.65
ABBV:
$2.38
EPD:
14.27
ABBV:
91.23
EPD:
1.57
ABBV:
6.30
EPD:
$52.60B
ABBV:
$61.16B
EPD:
$7.17B
ABBV:
$44.85B
EPD:
$9.92B
ABBV:
$28.29B
Returns By Period
In the year-to-date period, EPD achieves a 19.96% return, which is significantly higher than ABBV's -4.05% return. Over the past 10 years, EPD has underperformed ABBV with an annualized return of 12.26%, while ABBV has yielded a comparatively higher 19.07% annualized return.
EPD
- 1D
- -3.17%
- 1M
- 4.70%
- YTD
- 19.96%
- 6M
- 25.15%
- 1Y
- 18.72%
- 3Y*
- 21.83%
- 5Y*
- 19.58%
- 10Y*
- 12.26%
ABBV
- 1D
- 2.05%
- 1M
- -6.29%
- YTD
- -4.05%
- 6M
- -4.63%
- 1Y
- 7.29%
- 3Y*
- 15.00%
- 5Y*
- 19.40%
- 10Y*
- 19.07%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EPD vs. ABBV — Risk / Return Rank
EPD
ABBV
EPD vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enterprise Products Partners L.P. (EPD) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EPD | ABBV | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.00 | 0.27 | +0.73 |
Sortino ratioReturn per unit of downside risk | 1.40 | 0.54 | +0.86 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.07 | +0.13 |
Calmar ratioReturn relative to maximum drawdown | 1.23 | 0.53 | +0.70 |
Martin ratioReturn relative to average drawdown | 3.48 | 1.17 | +2.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| EPD | ABBV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.00 | 0.27 | +0.73 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.15 | 0.86 | +0.29 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | 0.74 | -0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.54 | 0.74 | -0.20 |
Correlation
The correlation between EPD and ABBV is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
EPD vs. ABBV - Dividend Comparison
EPD's dividend yield for the trailing twelve months is around 5.75%, more than ABBV's 3.06% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPD Enterprise Products Partners L.P. | 5.75% | 6.74% | 6.63% | 7.51% | 7.79% | 8.20% | 9.09% | 6.23% | 6.97% | 6.29% | 5.88% | 5.90% |
ABBV AbbVie Inc. | 3.06% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
Drawdowns
EPD vs. ABBV - Drawdown Comparison
The maximum EPD drawdown since its inception was -58.78%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for EPD and ABBV.
Loading graphics...
Drawdown Indicators
| EPD | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.78% | -45.09% | -13.69% |
Max Drawdown (1Y)Largest decline over 1 year | -15.40% | -16.74% | +1.34% |
Max Drawdown (5Y)Largest decline over 5 years | -18.06% | -21.92% | +3.86% |
Max Drawdown (10Y)Largest decline over 10 years | -58.04% | -45.09% | -12.95% |
Current DrawdownCurrent decline from peak | -3.67% | -9.64% | +5.97% |
Average DrawdownAverage peak-to-trough decline | -10.17% | -10.70% | +0.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.44% | 8.12% | -2.68% |
Volatility
EPD vs. ABBV - Volatility Comparison
The current volatility for Enterprise Products Partners L.P. (EPD) is 5.70%, while AbbVie Inc. (ABBV) has a volatility of 7.57%. This indicates that EPD experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| EPD | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.70% | 7.57% | -1.87% |
Volatility (6M)Calculated over the trailing 6-month period | 11.89% | 19.03% | -7.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.77% | 27.12% | -8.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.08% | 22.61% | -5.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.26% | 25.71% | -1.45% |
Financials
EPD vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Enterprise Products Partners L.P. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EPD vs. ABBV - Profitability Comparison
EPD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Enterprise Products Partners L.P. reported a gross profit of 2.00B and revenue of 13.79B. Therefore, the gross margin over that period was 14.5%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.
EPD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Enterprise Products Partners L.P. reported an operating income of 1.94B and revenue of 13.79B, resulting in an operating margin of 14.1%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.
EPD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Enterprise Products Partners L.P. reported a net income of 1.64B and revenue of 13.79B, resulting in a net margin of 11.9%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.